Cataldo Tony 4
4 · GT Biopharma, Inc. · Filed Feb 13, 2019
Insider Transaction Report
Form 4
Cataldo Tony
DirectorChairman and CEO
Transactions
- Sale
common stock
2019-02-06$0.00/sh−800,000$800→ 4,029,600 total
Footnotes (1)
- [F1]This a stock pledge for nominal consideration in a private transaction for a personal family matter.